Back to top

Telesis Bio, Regeneron partner for rapid DNA, gene synthesis

Telesis Bio (TBIO) announced a new license agreement with Regeneron Pharmaceuticals (REGN) to deploy Telesis Bio’s Gibson SOLA platform at its R&D ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Regeneron Pharmaceuticals, Inc. (REGN)

Telesis Bio Inc. (TBIO)